Disposition of (14)C and/or (74)As-cacodylic acid in rats after intravenous, intratracheal, or peroral administration by Stevens, J. T. et al.
Environmental Health Perspectives
Vol. 19, pp. 151-1S7, 1977
Disposition of 14C and/or
74As-Cacodylic Acid in Rats after
Intravenous, Intratracheal, or
Peroral Administration
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L. C. DiPasquale,* N. Chernoff,* and
W. F. Durham*
The distribution, excretion, and possible metaboism of 14C- and/or 74As-cacodylic acid, an organoar-
senical herbicide, was studied in rats following a single intravenous injection, intratracheal instillation or
oral gavage. Male Sherman rats were dosed at levels ranging from 200 mg/kg to 120 ,g/kg. The extent
and rate oflung absorption was greater than gastrointestinal absorption. Concentrations in the liver and
whole blood were higher after peroral dosing than intravenous administration. Levels observed in plasma
and other tissues were similar after all three routes following the absorptive phase. The percent dose
found in the whole blood, red blood cells, and plasma was similar for all doses given by these routes. Less
than 0.1½ ofthe administered dose was recovered as "4CO2 by any route at 24 hr after administration.
Twenty-four hours afterintravenous, intratracheal, and peroral administration, 71, 60, and 25%, respec-
tively, was excreted in the urine. After intravenous administration of200 mg/kg, sufficient 14C-cacodyllc
acid was recovered in bile to account for the small amount excreted in the feces. Cacodylic acid is
probably not metabolized to inorganic arsenic since the disposition of 14C and 74As-cacodylic acid were
identical.
Kinetic analyses ofthe plasma curve for 14C-cacodylic acid (high dose) yielded three half-times; 0.014,
0.214 and 3.42 hr with an apparent volume ofdistribution of 15.3 ml. Highest initial concentrations were
found in the whole blood, muscle, kidney, liver and lung.
Levels in all tissues decreased rapidly, but remained high in whole blood. The red blood cells were
found to be the major site of body burden ofcacodylic acid.
Introduction
The organoarsenical compound cacodylic acid
(dimethylarsenic acid) is a nonselective herbicide
used for control ofweeds in noncrop areas, for cot-
ton defoliation, for control of hardwood trees, and
for suppression of bark beetles. Although the com-
pound has been known for over 130 yr (1), it was
introduced into use as a herbicide only in 1958.
*Environmental Toxicology Division, Health Effects Re-
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A number of studies are available on the acute,
subacute, and long-term toxicity of cacodylic acid
to laboratory (2, 3) and domestic animals (4), and
use experience has provided information on its
hazard for man (5). Little information, however,
has been published on the pharmacodynamic as-
pects of exposure in experimental animals or man
for either cacodylic acid or the closely related
monosodium methanearsenate (MSMA) and di-
sodium methanearsenate (DSMA).
This paper describes studies on the absorption,
distribution, storage, metabolism, and excretion of
radiolabeled cacodylic acid in rats. Routes of ex-
posure used include intravenous injection, intra-
tracheal instillation, and oral gavage.
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Young male Sherman strain rats were obtained
from the Center for Disease Control, Atlanta,
Georgia, and allowed to acclimatize in our animal
quarters. Rats used in the study were determined to
have normal weight gain and urinalysis
[Combistix, Ames]. The rats weighed 280-380 g
and were not fasted before treatment. Time-
pregnant CD rats (Charles Rivers, Inc.), were used
in the placental transfer studies. 14C- and 74As-
(half-life = 18 days) labeled cacodylic acid was
synthesized by ICN Pharmaceuticals, Inc., Irvine,
California. For the dual label experiments, aliquots
of the 14C- and 74As-cacodylic acid were mixed.
The specific activity ofthe 14C- and 74As-cacodylic
acid was 10 mCi/mmole and 2 mCi/mmole, respec-
tively. The radiochemical purity was reported and
confirmed to be 99% by autoradiographic thin-layer
chromatography.
Lung absorption of "4C-cacodylic acid was de-
termined after the method of Enna and Schanker
(6). A PE 240 cannula was inserted as a guide be-
tween the fourth and fifth tracheal ring of chloral
hydrate anesthetized rats to a depth of6 mm. Dos-
ing was accomplished through a smaller rubber
cannula permitting passage only to the bifurcation
of the trachea. A 100 ,ul portion of solution was
administered for a dose of78 mg/kg. The lungs and
trachea were removed at 0, 5, 10, and 20 min and
assayed for the amount of "4C-cacodylic equiva-
lents remaining.
Peroral absorption kinetics were estimated by
sacrificing 4 hr after administration and counting
the entire gastrointestinal tract for percent of dose
remaining.
For the intravenous and oral high dose studies,
cacodylic acid (Fisher Scientific Co., 95%
cacodylic acid and 5% water) at a concentration of
60 mg/ml and labeled with 14C-cacodylic acid to an
activity of 530 ,uCi/ml was used.
Rats were dosed intravenously with 200 mg/kg
(0.5 ml/150 g body weight) via the tail vein and sac-
rificed at 0.117, 0.25, 1.0, 24, and 72 hr after ad-
ministration. The concentration of "4C-cacodylic
acid-equivalent was assayed in blood, lung, liver,
brain, spleen, and kidney. Additional animals were
dosed similarly for the blood clearance. Whole
blood was collected at selected intervals from the
intraorbital sinus in a 50 ul heparinized capillary
tube. The sample was then centrifuged in a mi-
crohematocrit centrifuge, the hematocrit deter-
mined, and the sample divided into plasma and red
blood cells by severing the capillary tube by use ofa
diamond glass scribe. The plasma and cells were
then processed for counting.
Biliary secretion was measured in pentobarbital
anesthetized rats by cannulating the common bile
duct with PE 10 tubing and collectingquantitatively
the biliary secretion in microcapillary tubes for
assay.
Intratracheally instilled rats were given 0.1
ml/150 g ofbody weight of 14C-cacodylic acid for a
dose of 200 mg/kg (53 uCi/ml). Rats were anes-
thetized with ether or 0.5 ml ofchloral hydrate (200
mg/kg) and a catheter (approximately 3 cm) with an
internal diameter of 1.68 mm positioned surgically.
Animals were allowed to recover from anesthesia
and dosed by using a cannula with an external
diameter of 1.09 mm to allow breathing during dos-
ing. The cannula was inserted approximately 5 cm
to the tracheal bifurcation. Whole blood was col-
lected from the intraorbital sinus as described pre-
viously. All tissues and fluids were digested in 2 ml
of NCS Biological Solubilizer (Amersham/Searle),
15 ml of scintillation counting fluid added, and
counted (Mark III/Searle Analytic Inc.).
Additional animals were dosed by the three
routes and placed in animal containment chambers
(Plas-Labs, Lansing, Michigan) and all effluent was
passed through Carbo-sorb II (Packard) for 14CO2
collection.
For low dose administration, adult Sherman and
CD rats were given a fixed volume of 0.5 ml of
aqueous solution containing 33 ,ug of 14C-cacodylic
acid and amounts of 74As-cacodylic acid ranging
from 3.47 to 13.88 ,g. It was necessary toadjust the
amount of 74As-cacodylic acid because of its short
half-life. The dose was given intravenously via the
tail vein, intratracheally or perorally. Intratracheal
installation was done in methohexital anesthetized
animals. The administration was facilitated with an
18 gauge needle guided to the tracheal bifurcation
while using an otoscope light source.
The following tissues were taken at selected
times post administration: blood, heart, lung,
spleen, kidney, liver, brain, testes and femoral
muscle. Tissues were homogenized in 4 volumes of
0.85% saline per gram oftissue by using a Polytron
homogenizer. A 250 ,ul aliquot sample was taken
and digested in 1 ml of NCS (12 hr). Whole blood
was collected in a 10 ml heparinized Vacutainer
(Becton-Dickinson) from the abdominal aorta un-
less otherwise specified. Plasma and red blood cells
were also harvested.
Both 14C and 74As isotopes were counted by
using Beta counting techniques. 14C was evaluated
at a 200 keV energy level and 74As at 700 keV
energy level. 14C had a counting efficiency of 63%
in the dual isotope program used. A theoretical effi-
ciency of 74As of38% was calculated based on the
specific activity of 74As on the day of shipment
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for the two isotopes individually and in combina-
tion. Any spillover in energy levels were consid-
ered. Known standards were run daily to correct for
decay of 74As label. Radioarsenic was also deter-
mined by gamma spectrometry with an Auto-
Gamma Scintillation Spectrometer (model 5986)
and a Armac Scintillation Spectrometer (Packard
Instrument Co.).
Whole blood volume and muscle mass was esti-
mated by using published procedures: 0.055 x body
weight0O99 (7), and 0.45 x body weight, respec-
tively (8). Plasma volumes were estimated from
hematocrit values and the whole blood volume.
Results
The results of studies to determine lung and gas-
trointestinal absorption in the rat are shown in Fig-
ure 1. It can be seen that cacodylic acid is rapidly
absorbed from the rat lung, with less than 5% re-
maining at 15 min. The half-time for absorption
from the lung was found to be 2.2 min. The esti-
mated half-time for peroral absorption was found to
be 248 min.
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FIGURE 1. Pulmonary absorption of 78 mg/kg of '4C-cacodylic
acid and gastrointestinal absorption of 33 ,ug of 14C- and 6.9
,ug of 74As-cacodylic acid by male Sherman rats.
The mean intravenous plasma '4C-cacodylic acid
(200 mg/kg) data (Fig. 2) were analyzed for decay
constants and intercepts by nonlinear least squares
techniques on a digital computer. This procedure
yielded a three-exponential equation with half-times
of 0.014 hr, 0.217 hr and 3.42 hr and an apparent
volume of distribution of 15.3 ml.
Figure 3 characterizes the plasma curves for the
administration of33 ,ug of 14C-cacodylic acid by the
intravenous, intratracheal, and peroral routes. The
maximal concentration after intracheal administra-
tion was seen at 5 and 10 min, and similar curves
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FIGURE 2. Kinetic analysis ofthe plasma curve obtained after the
administration of 200 mg/kg of "4C-cacodylic acid to male
Sherman rats.
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FIGURE 3. Comparison of plasma curves after (e) intravenous,
(A) intratracheal, and (s) peroral administration of 33 ,tg of
"4C-cacodylic acid and 3.5, 13.8 and 6.9 ,g of74As-cacodylic
acid given to male Sherman rats.
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153were found for intravenous and intratracheal
plasma clearance. The much slower absorption
from the gastrointestinal tract resulted in peak
plasma levels around 1 hr. A comparison of whole
blood levels after the three routes ofexposure (Fig.
4) shows that higher concentrations are achieved
after peroral administration and that significant
pulmonary clearance and gastrointestinal absorp-
tion as reflected by the positive slope occurs after
intracheal administration (insert, Fig. 4). The clear-
ance of cacodylic acid from the whole blood after
intravenous, intratracheal and peroral administra-
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FIGURE 4. Comparison of whole blood curves after (.) intra-
venous, (A) intratracheal, and (i) peroral administration of
"4C-cacodylic acid and 3.5, 13.8 and 6.9 Mug of74As-cacodylic
acid given to male Sherman rats.
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FIGURE 5. Comparison of whole blood and plasma levels after
the intravenous and intratracheal administration of200mg/kg
of 14C-cacodylic acid.
Table 1. Whole blood leels 24 hr after one or five doses of
cacodylic acid given peroral to male Sherman rats.
No. of doses 4s, ng/ml < SEMa
1 45.2 ± 3.33
4 178 ± 13.1
aAdministered adose of 12.7 AG of14C-cacodylic acid and 3.4
Mg of 74As-cacodylic acid.
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Table 2. Distribution of radiolabel after intravenous administra-
tion of cacodylic acid to adult male Sherman rats
(dose comparison).
% ofdose recovered
15 min I hr
Organ Higha LoWb Higha Lowb
Lung 0.61 0.44 0.31 0.25
Liver 9.81 5.00C 1.08 1.34
Brain 0.08 0.03 0.05 0.05
Spleen 0.20 0.12 0.08 0.05
Kidneys 2.98 4.69c 0.68 0.88
Whole blood 12.5 11.01 14.8 11.0
aMean ofat least three animals given 200 mg/kg"4C-cacodylic
acid.
bMean of four animals given 33 ,tg of"4C-cacodylic acid and
3.47 ,ug of74As-cacodylic acid.
CDifferent at P < 0.05.
Table 3. Distribution of radiolabel after intravenous administra-
tion of 74As- and 74C-cacodylkc acid to adult male Sherman rats
(label comparison).
Radio % of dose recovered/tissue
Organ labela 5 min 4 hr 48 hr 60 days
Heart 14C 0.24 0.06 0.06 0.03
74As 0.23 0.08 0.07 0.04
Lung 14C 0.73 0.21 0.23 0.09
74As 0.60 0.19 0.19 0.11
Spleen 14C 0.13 0.12 0.08 0.05
74As 0.10 0.10 0.10 0.05
Kidneys 14C 7.69 0.13 0.12 0.05
74As 8.36 0.12 0.10 0.09
Liver 14C 6.32 0.55 0.58 0.23
74As 6.90 0.54 0.50 0.15
Testes 14C 0.39 0.06 0.03 0.01
74As 0.41 0.06 0.03 0.02
Muscle 14C 12.8 1.58 1.31 0.44
74As 14.3 1.23 1.33 0.37
aRats were given 11.6 mCi of14C (33 ug ofcacodylic acid) add
5 mCi of74As (3.47 ,ug ofcacodylic acid); 14C measured by beta
emission; 74As, by gamma emission.
Table 4. Distribution of"'C-cacodylic acid and/or its metabolites in
certain organs of male Sherman rats after intravenous ad-
ministration.
% of dose recovered
Organ 1 min 15 min 1 hr 72 hr 168 hr
Lung 1.86a 0.61 0.31 0.22 0.13
Liver 1.97 9.81 1.08 0.33 0.30
Brain 0.18 0.08 0.08 0.05 0.02
Spleen 0.19 0.20 0.15 0.08 0.05
Kidney 2.23 2.98 0.68 0.05 0.07
Whole
blood 30.5 12.5 14.7 14.8 9.9
aMean ofat least three animals given 200 mg/kg 14C-cacodylic
acid (8.8 ,uCi/mg).
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adult male Sherman rats (route comparison).a
ng/g
Tissue Intravenous Intratracheal Peroral
Heart 4.86 ± 1.55 (0.02)b 7.39 ± 1.70 (0.02) 8.47 ± 1.33 (0.05)
Lung 16.8 ± 1.22 (0.09) 20.2 ± 5.40 (0.07) 24.8 ± 5.93 (0.11)
Spleen 15.8 ± 2.87 (0.03) 41.2 ± 7.81c (0.07) 31.5 ± 7.87 (0.06)
Liver 5.86 ± 0.66 (0.19) 5.58 ± 2.56 (0.29) 15.7 ± 5.69 (0.54)
Kidney 5.75 ± 0.33 (0.04) 13.9 ± 2.70c (0.08) 9.68 ± 1.82 (0.07)
Brain 1.66 ± 0.22 (0.01) 2.84 ± 1.28 (0.01 1.82 ± 0.48 (0.01)
Testes 1.22 ± 0.22 (0.02) 1.28 ± 0.14 (0.01) 1.69 ± 0.12 (0.02)
Muscle 0.88 ± 0.22 (0.47) 0.85 ± 0.28 (0.33) 0.85 ± 0.36 (0.45)
GAll animals given a single 33 jug dose of -C.cacodylic acid with 3.5 ,ug intravenously, 13.8 ,ug intracheally, and 6.9 ,ug
perorally of74As-cacodylic acid.
bMean percent of total dose per tissue parenthesis (N = 4).
CDifference from intravenous dose at p < 0.05.
tion displayed half-times of approximately 92, 76,
and 90 days, respectively. It should be noted that
higher blood levels were achieved after a single
peroral dose than similar dosing by other routes al-
though five consecutive daily peroral doses resulted
in lower blood levels at 105 days.
Comparison ofwhole blood levels 24 hr after one
and four daily peroral doses (Table 1) indicates
linear accumulation of "4C-label after multiple dos-
ing (3.9 times the single dose).
Data which compare whole blood and plasmadis-
tribution after intravenous and intratracheal instilla-
tion (200 mg/kg) are presented in Figure 5. Al-
though cacodylic acid is retained by the whole
blood, it is rapidly eliminated from the plasma.
Since the plasma and whole blood data that have
been presented were obtained after different levels
of dosing, it is important to consider the matter of
dose dependency. The data given in Table 2 ad-
dress this issue. It can be seen that, with the excep-
tionofdifferences observed in levels in the liverand
kidney at 15 min, no significant differences in the
percent dose recovered in tissues or whole blood
was observed after the administration of different
dose levels. Data given in Table 3 indicate no sig-
nificant differences in distribution after intravenous
dosing in 14C- or 74As-labeled cacodylic acid.
The distribution of 14C-cacodylic acid (200
mg/kg) given intravenously is shown in Table 4.
Despite arapid decline in tissue levels, whole blood
tends to retain the 14C-label.
Although differences in whole blood levels after
intravenous, intratracheal and peroral dosing were
noted at 105 days (Fig. 4), only three differences
were noted in tissue levels at this time (Table 5).
The level of "4C-label in the spleen and kidney were
higher after intratracheal instillation than after in-
travenous and higher levels were observed in the
liver after peroral dosing when compared to in-
travenous.
The results presented in Table 6 indicate that
three tissues, the spleen, kidney, and brain, have
higher levels of 14C-label after multiple oral dosing.
Elimination and retention of cacodylic acid is
shown in Table 7. More cacodylic acid is retained
after peroral administration than either intravenous
or intracheal. The primary route of excretion after
peroral dosing was fecal. Urinary excretion was
lower after peroral dosing when compared with
other routes.
The demethylation of 14C-cacodylic acid was
evaluated. These results (Table 8) show that only a
small fraction of the dose was evolved as 14CO2. It
should be noted that an approximately 10-fold
higher level of 14CO2 is eliminated by the peroral
route when compared to other routes.
Approximately 1% of the dose administered in-
travenously was eliminated in the feces (Table 7).
Table 6. Tissue distribution of radiolabel 105 days after a single
dose or five doses of cacodylic acid perorally (number of dose
comparison).
% ofdoses/organ
Tissue Single dosea Five dosesb
Heart 0.05 (0.0340.10)c 0.08 (0.29-0.09)
Lung 0.11 (0.09-0.18) 0.13 (0.09-0.19)
Spleen 0.06 (0.03-0.10) 0.12 (0.11-0.14"
Liver 0.54 (0.23-1.17) 0.53 (0.11-0.58)
Kidney 0.07 (0.04-0.08) 0.17 (0.110.18)d
Brain 0.01 (0.01-0.02) 0.02 (0.02-0.04)d
Testes 0.02 (0.01-0.02) 0.02 (0.02-0.03)
Muscle 0.45 (0.24-0.86) 0.55 (0.44-0.78)
aRats given 33 ,ug of 14C-cacodylic acid and 6.9 ,Ag of
74As-cacodylic acid.
bRats given 12.7 ,ug of '4C-cacodylic acid and 3.4 ,ug of
74As-cacodylic acid (times 5).
cMean (range); N = 4.
dDifferent at p <0.05.
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Percent ofdose
Route Whole body Urine Feces Total % Absorbed
Intravenousa 20.5 (16.1-26.9) 70.9 (57.7-80.2) 1.18 (0.2-2.9) 92.6 100
Oralb 31.8 (25.0-46.4) 25.2 (20.1-28.7) 31.1 (27.4-36.9) 88.1 66
Intrachealc 24.3 (16.7-31.7) 60.0 (43.2-78.3) 8.32 (3.9-14.1) 92.6 92
aRats given 33 ,ug of 14C-cacodylic acid and 3.5 ,ug of 74As-cacodylic acid.
bRats given 33 gg of"4C-cacodylic acid and 6.9 ug of 74As-cacodylic.
cRats given 33 ,g of"C-cacodylic acid and 13.8 ,g of 74As-cacodylic acid.
Table 8. Eliminadon of "4C-cacodylic acid as 14C-CO2 after in-
travenous, intratracheal, and peroral administration to male rats.
Sampling Cumulative % of dosea
times
afterdosing,hr Intravenous Intracheal Peroral
0.5 2.9 x 10-3 1.1 X 10-3 1.5 x 10-2
1 2.9 x 10-3 3.7 x 10-3 4.1 x 10-2
2 4.4 x 10-3 5.2 x 10-3 4.9 x 10-2
4 7.2 x 10-3 6.9 x 10-3 6.2 x 10-2
24 7.9 x 10-3 b 13 x 10-2
aRats given 200 mg/kg of14C-cacodylic acid by all routes.
bSample not taken.
Experiments indicate that cacodylic acid is ex-
creted in the bile (Table 9).
All the data previously presented were obtained
using the male Sherman rat as the model. Compari-
son of male and female rat tissue distribution of
cacodylic acid at 1 and 72 hr after a single intrave-
nous dose indicate no sex-related differences in con-
centration (Table 10).
Table 9. Biliary secretion of 14C-cacodylic acid after intravenous
dosage (200 mg/kg).
Time
of
collection, hr
0.25
0.5
2
2
Average
volume,
ml ± error
0.22 ± 0.02
0.25 ± 0.03
0.32 ± 0.03
0.54 ± 0.07
Average
secreted,
,ug ± error4
0.38 ± 0.05
0.38 ± 0.01
0.31 ± 0.01
0.44 ± 0.10
Cumulative
% of dose
0.057
0.114
0.161
0.226
"Two rats anesthetized with 50 mg of pentobarbital; common
bile duct cannulated with PE 10 tubing.
Cacodylic acid readily crosses the placenta
(Table 11) 24 hr prior to parturition. Levels ob-
tained in the whole blood of the fetus were not dif-
ferent than the maternal levels. Comparison with
maternal tissue levels indicate differences in fetal
tissue concentrations for brain and kidney but not
liver.
Discussion
Cacodylic acid is absorbed from the rat lung and
gastrointestinal tract. Plasma and whole blood
curves obtained after intratracheal instillation are
similar to those obtained after intravenous ad-
ministration. The slower absorption of cacodylic
acid after peroral administration is reflected in
plasma and whole blood data. The estimated gas-
trointestinal half-time of 248 min agrees well with
the 209 minute value reported by Hwang and
Schanker (9). The absorption after peroral and in-
tracheal administration was 66 and 92%, respec-
tively.
Cacodylic acid has a high affmity for the rat eryth-
rocyte as evidenced by the rapid transfer from the
serum fraction and the retention in the whole blood.
It is well established that the rat differs from other
tested species in its erythrocyte affinity forinorganic
arsenic (8, 10). The data presented in this study indi-
cate a half-time of 90 days, which agrees well with
the mean life of rat' red blood cell (8).
Despite the fact that single dose peroral adminis-
tration leads to higherwhole bloodlevels than intra-
Table 10. Distribution of radiolabel after administration of 200 mg/kg 14C-cacodylic acid to
adult Sherman rats (sex comparison).
Avg. Time Tissues, ,ug equivalents/g + SEM
dose post
mg/SEM dosing, hr Sex Liver Lung Brain Spleen Kidneys
34±2 1 Male 47±3 (1.1)a 89±19 (0.26) 14±3 (0.07) 70±16 (0.15) 144±13 (0.68)
25+2 1 Female 61±6 (1.3) 93±9 (0.28) 16±2 (0.10) 77±1 (0.14) 122±7 (0.52)
32+3 72 Male 16±2 (0.36) 74±5 (0.24) 11±4 (0.06) 53±2 (0.09) 12±2 (0.06)
24±1 72 Female 14±1 (0.33) 68±6 (0.25) 11±1 (0.07) 61+3 (0.10) 15±1 (0.07)
aNumbers in parentheses equals denote percentofdose/organ; meanoffouranimalsgiven 200mg/kg of"4C-cacodylic acid.
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of74As and 4C-cacodylic acid to adult pregnant CD-1 ratonday21
gestation (placental transfer).
Maternal, Fetal,
Fluid or ng/ml ng/ml
tissue or ng/ga or ng/g
Whole blood 228 ± 24 192 + 31
Brain 2.76 ± 24 1.21 ± 0.1b
Kidney 1.2 ± 2.06 2.46 ± 0.29b
Liver 19.17 ± 2.28 16.9 ± 1.78
Urine 21170 ± 720 (64.2)c
aSince no difference was observed between percent 74As and
13C-cacodylic acid only 14C data are given; mean offive values ±
SEM (litters taken as a unit) ng equivalents after 33 ,g dose of
14C-cacodylic acid and 3.5 ,ug of 74As-cacodylic acid.
bDifferent at P > 0.05.
cAs equivalents excreted in 24 hr ± SEM (% ofdose).
tracheal and intravenous dosing and the adminis-
tration of five daily doses produces whole blood
levels four times as high as a single dose, at 105
days the percent of dose remaining in the whole
blood after five daily peroral doses was less than
that after a single dose by other routes. The total
amount of cacodylic acid administered with the
multiple dosing was approximately 80 ,ug compared
to 40 ag given in a single dose. It is unlikely that
reduced retention by the erythrocytes is related to
absorption or cellular damage.
Cacodylic acid does not appear to be converted
from organic to inorganic arsenical since the tissue
distribution of 74As- and 14C-labeled cacodylic acid
were not different. The present experimental re-
sults do not exclude possible changes in the valence
states of the arsenic however.
High transient levels of cacodylic acid were
found in muscle, kidneys, liverand lung. Lanz et al.
(8) observed a similar distribution after administer-
ing carrier-free 74As. At 105 days after a single
dose, detectable levels ofcacodylic acid were found
in all tissues evaluated. Highest concentrations
were found in the lung and spleen. More radiolabel
was recovered in the spleen and kidney ofratsgiven
cacodylic acid intratracheally than intravenously.
More cacodylic acid was found in the liver ofperor-
ally dosed rats than those treated intravenously.
The reasons for these differences are not under-
stood at this time.
Despite lower whole blood levels found at 105
days after multiple oral dosing as compared to a
single dose, a higher percent of the dose was re-
covered in the spleens, kidneys and brains after
multiple dosing.
The excretion of cacodylic acid was very rapid,
with more than 60% of the dose being excreted in
the urine after intravenous and intratracheal ad-
ministration and only minor amounts being ex-
creted in the feces while after peroral dosing 25% of
the dose was recovered in the urine and 31% in the
feces. Secretion of the arsenical into the bile ex-
plains the small amount found in the feces after in-
travenous administration. Only minor amounts of
label were evolved as 14C02.
Studies did not indicate any sex-related differ-
ences in the distribution of cacodylic acid. It was
also found that cacodylic acid can pass the placental
barrier just prior to parturition, achieving levels in
the whole blood of the fetus comparable to the ma-
ternal animal.
Mention ofcommercial products does not imply endorsement
by the United States Environmental Protection Agency.
REFERENCES
1. Bunsen, R. Untersuchugen uber die Kakodylreihe, Ann.
Chem., 46:1 (1843).
2. Nees, P. 0. Report on cacodylic acid toxicity to animals,
Wisconsin Alumni Research Foundation, EPA Pesticide
Petition No. OF0911 (1960). Cited in Initial Scientific Re-
view of Cacodylic Acid, EPA-540/1-75-021 Dec. 1975.
3. Innes, J. R. M., et al. Bioassay ofpesticides and industrial
chemicals for tumorigenicity in mice: a preliminary note. J.
Nat. Cancer Inst. 42: 1101 (1969).
4. Peoples, S. A. Toxicity of cacodylic acid to animals. Uni-
versity of California, School of Veterinary Science, EPA
Pesticide Petition No. OF0911 (1963). Cited in Initial Scien-
tific Review of Cacodylic Acid. EPA-540/1-75-021 Dec.
1975.
5. Tarrant, R. F., and Allard, J. Arsenic levels in urine of
forest workers applying silvicides. Arch. Environ. Health,
24: 277 (1972).
6. Enna, S. J., and Schanker, L. S. Absorption ofdrugs from
the rat lung, Am. J. Physiol. 222: 409 (1972).
7. Spector, W. S., Ed. Handbook ofBiological Data, USAF,
Wright Patterson Air Force Base, Ohio, 1957, p. 355.
8. Lanz, H., Jr., Wallace, P. C., and Hamilton, J. G. The
metabolism ofarsenic in laboratory animals using 74As as a.
tracer. University ofCalif. Publ. Pharmacol. 2: 263 (1950).
9. Hwang, S. W., and Schanker, L. S. Absorption of organic
arsenical compounds from the rat small intestine.
Xenobiotica 3: 351 (1973).
10. Hunter, F. T., Kip, A. F., and Irvine, J. W., Jr. Radioac-
tive tracer studies on arsenic injected as potassium arsenite.
J. Pharmacol Exptl. Therap. 76: 207 (1942).
August 1977 157